Physician profile
Renee E Nydegger
NPI 1154311728
$490.59
in general payments reported to CMS, 2019-2025
13 companies · $20.07 in 2025
The $20.07 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $72.12 · 2021: $143 · 2023: $18.98 · 2024: $44.33 · 2025: $20.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $83.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $83.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $106.32 | 2019-2024 | Otezla, Repatha |
| Janssen Pharmaceuticals, INC | $87.09 | 2020-2021 | |
| Novo Nordisk INC | $46.01 | 2019-2025 | Rybelsus, Ozempic |
| Abbvie INC. | $41.79 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $36.36 | 2019-2020 | |
| Glaxosmithkline, LLC. | $34.74 | 2019 | |
| Sanofi Pasteur INC. | $31.71 | 2019-2023 | |
| Phathom Pharmaceuticals, INC. | $30.05 | 2024 | Voquezna |
| Biohaven Pharmaceuticals, INC. | $22.12 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.54 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.68 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.17 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Nydegger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.